Application of thrombolysis with rt-PA and edaravone in treatment of embolic stroke in the rat

WANG Ping,LI Xiao-gang
DOI: https://doi.org/10.3969/j.issn.1009-0126.2008.09.018
2008-01-01
Abstract:Objective To examine the efficacy of the free radical scavenger edaravone as an adjuvant for thrombolytic therapy with recombinant human tissue plasminogen activator(rt-PA)in a rat model of embolic stroke.Methods A rat model of embolic stroke was set up by embolizing the middle cerebral artery with thrombus.Eighty-four SD rats were randomly divided into 4 groups of 21 rats each:(1)the sham operation group,(2)the model group without treatment,(3)rt-PA group,(4)edaravone combined with rt-PA group.Each rat of group(4)was given IV injection of 5 mg/kg of rt-PA and 3 mg/kg of edaravone following 3 hours of ischemia.Twenty-four hours later neurological functional deficit score and the size of the brain infarct were assessed.The injury of BBB after cerebral ischemia-reperfusion was assessed by determination of Evans blue(EB)content in brain tissue and immunohistochemistry method.Results After 24 hours of rt-PA thrombolysis,the sizes of brain infarcts in rats of group 4 were obviously smaller than those in rats of group 3(P<0.01).The EB content in brain tissue was significantly decreased in group 4 compared with group 3(P<0.01).The enodothelial barrier antigen(EBA)expression of BBB in group 4 was significangtly higher than that in group 3(P<0.05).The expression of fibrinogen around microvessels was significantly decreased in group 4(P<0.05).Conclusions Thrombolysis with combination of edaravone and rt-PA at 3 hours after ischemia significantly reduces infarct volume and improves neurological function.
What problem does this paper attempt to address?